Youngy Health Co., Ltd. (300247.SZ)
CNY 4.09
(-0.97%)
CNY 4.09
(-0.97%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 529.44 Million CNY | 14.27% |
| 2022 | 463.31 Million CNY | -12.0% |
| 2021 | 526.5 Million CNY | 2.42% |
| 2020 | 514.08 Million CNY | -29.59% |
| 2019 | 730.15 Million CNY | -31.34% |
| 2018 | 1.06 Billion CNY | -12.7% |
| 2017 | 1.21 Billion CNY | 102.91% |
| 2016 | 600.29 Million CNY | 39.86% |
| 2015 | 429.21 Million CNY | 51.07% |
| 2014 | 284.12 Million CNY | 7.2% |
| 2013 | 265.04 Million CNY | 8.04% |
| 2012 | 245.31 Million CNY | 18.31% |
| 2011 | 207.35 Million CNY | 5.46% |
| 2010 | 196.61 Million CNY | 15.29% |
| 2009 | 170.54 Million CNY | 18.31% |
| 2008 | 144.15 Million CNY | 35.86% |
| 2007 | 106.1 Million CNY | 15.18% |
| 2006 | 92.12 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 176.33 Million CNY | 13.56% |
| 2024 Q3 | 142.41 Million CNY | -9.32% |
| 2024 Q2 | 157.04 Million CNY | -10.94% |
| 2023 Q3 | 102.96 Million CNY | -8.83% |
| 2023 FY | 529.44 Million CNY | 14.27% |
| 2023 Q4 | 155.27 Million CNY | 50.8% |
| 2023 Q2 | 112.94 Million CNY | -28.63% |
| 2023 Q1 | 158.25 Million CNY | 19.3% |
| 2022 Q2 | 112.91 Million CNY | -8.37% |
| 2022 Q1 | 123.22 Million CNY | -22.36% |
| 2022 Q3 | 94.52 Million CNY | -16.29% |
| 2022 FY | 463.31 Million CNY | -12.0% |
| 2022 Q4 | 132.65 Million CNY | 40.34% |
| 2021 Q2 | 126.45 Million CNY | -10.92% |
| 2021 Q3 | 99.37 Million CNY | -21.42% |
| 2021 Q1 | 141.96 Million CNY | -10.24% |
| 2021 FY | 526.5 Million CNY | 2.42% |
| 2021 Q4 | 158.71 Million CNY | 59.71% |
| 2020 FY | 514.08 Million CNY | -29.59% |
| 2020 Q3 | 119.05 Million CNY | -3.24% |
| 2020 Q2 | 123.03 Million CNY | 8.09% |
| 2020 Q1 | 113.83 Million CNY | -42.95% |
| 2020 Q4 | 158.15 Million CNY | 32.84% |
| 2019 FY | 730.15 Million CNY | -31.34% |
| 2019 Q4 | 199.52 Million CNY | 11.56% |
| 2019 Q2 | 168.33 Million CNY | -8.23% |
| 2019 Q1 | 183.43 Million CNY | -46.05% |
| 2019 Q3 | 178.85 Million CNY | 6.25% |
| 2018 Q3 | 215.15 Million CNY | -12.71% |
| 2018 FY | 1.06 Billion CNY | -12.7% |
| 2018 Q1 | 261.72 Million CNY | -43.24% |
| 2018 Q4 | 340 Million CNY | 58.03% |
| 2018 Q2 | 246.47 Million CNY | -5.83% |
| 2017 FY | 1.21 Billion CNY | 102.91% |
| 2017 Q4 | 461.14 Million CNY | 49.3% |
| 2017 Q1 | 223.41 Million CNY | -20.5% |
| 2017 Q2 | 224.62 Million CNY | 0.54% |
| 2017 Q3 | 308.87 Million CNY | 37.51% |
| 2016 FY | 600.29 Million CNY | 39.86% |
| 2016 Q3 | 120.83 Million CNY | 28.2% |
| 2016 Q4 | 281 Million CNY | 132.55% |
| 2016 Q2 | 94.25 Million CNY | -9.55% |
| 2016 Q1 | 104.2 Million CNY | -35.78% |
| 2015 Q1 | 92.56 Million CNY | -0.98% |
| 2015 Q2 | 87.76 Million CNY | -5.18% |
| 2015 Q3 | 87.23 Million CNY | -0.61% |
| 2015 Q4 | 162.26 Million CNY | 86.02% |
| 2015 FY | 429.21 Million CNY | 51.07% |
| 2014 Q1 | 64.56 Million CNY | -28.44% |
| 2014 FY | 284.12 Million CNY | 7.2% |
| 2014 Q2 | 63.51 Million CNY | -1.63% |
| 2014 Q3 | 62.55 Million CNY | -1.51% |
| 2014 Q4 | 93.48 Million CNY | 49.45% |
| 2013 Q4 | 90.23 Million CNY | 75.01% |
| 2013 FY | 265.04 Million CNY | 8.04% |
| 2013 Q1 | 66.34 Million CNY | -27.06% |
| 2013 Q3 | 51.55 Million CNY | -9.4% |
| 2013 Q2 | 56.9 Million CNY | -14.22% |
| 2012 Q4 | 90.96 Million CNY | 52.79% |
| 2012 Q3 | 59.53 Million CNY | 7.75% |
| 2012 Q2 | 55.24 Million CNY | 39.61% |
| 2012 FY | 245.31 Million CNY | 18.31% |
| 2012 Q1 | 39.57 Million CNY | -46.02% |
| 2011 FY | 207.35 Million CNY | 5.46% |
| 2011 Q4 | 73.31 Million CNY | 51.05% |
| 2011 Q3 | 48.53 Million CNY | 2.4% |
| 2011 Q2 | 47.39 Million CNY | 24.4% |
| 2011 Q1 | 38.1 Million CNY | -47.84% |
| 2010 Q4 | 73.04 Million CNY | 53.02% |
| 2010 Q3 | 47.73 Million CNY | 0.0% |
| 2010 FY | 196.61 Million CNY | 15.29% |
| 2009 FY | 170.54 Million CNY | 18.31% |
| 2008 FY | 144.15 Million CNY | 35.86% |
| 2007 FY | 106.1 Million CNY | 15.18% |
| 2006 FY | 92.12 Million CNY | 0.0% |